Druggable Allosteric Sites in β-Propeller Lectins

Angew Chem Int Ed Engl. 2022 Jan 3;61(1):e202109339. doi: 10.1002/anie.202109339. Epub 2021 Nov 23.

Abstract

Carbohydrate-binding proteins (lectins) are auspicious targets in drug discovery to combat antimicrobial resistance; however, their non-carbohydrate drug-like inhibitors are still unavailable. Here, we present a druggable pocket in a β-propeller lectin BambL from Burkholderia ambifaria as a potential target for allosteric inhibitors. This site was identified employing 19 F NMR fragment screening and a computational pocket prediction algorithm SiteMap. The structure-activity relationship study revealed the most promising fragment with a dissociation constant of 0.3±0.1 mM and a ligand efficiency of 0.3 kcal mol-1 HA-1 that affected the orthosteric site. This effect was substantiated by site-directed mutagenesis in the orthosteric and secondary pockets. Future drug-discovery campaigns that aim to develop small molecule inhibitors can benefit from allosteric sites in lectins as a new therapeutic approach against antibiotic-resistant pathogens.

Keywords: NMR spectroscopy; allostery; carbohydrate-protein interactions; drug discovery; fragment-based drug design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Site / drug effects
  • Burkholderia / chemistry
  • Humans
  • Lectins / antagonists & inhibitors*
  • Lectins / metabolism
  • Molecular Structure
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*

Substances

  • Lectins
  • Small Molecule Libraries

Supplementary concepts

  • Burkholderia ambifaria